EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unlocking the Future of Alzheimer's Disease: Innovations in Diagnosis and Therapy

Man Mohan Mehndiratta, Monika Singla, Abhishek Dixit

Journal of The Association of Physicians of India · 2025

DOI: 10.59556/japi.73.1075 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of The Association of Physicians of India, 2025. Verfasst von Man Mohan Mehndiratta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Principal-Director Senior Consultant, Department of Neurology, BLK-Max Super Speciality Hospital; MAX Healthcare, Delhi, India, Corresponding Author. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is one of the most common forms of dementia, making up around two thirds of all dementia cases globally. Despite its high prevalence, it is estimated to remain undiagnosed in 41 million people with dementia, and with only about 25% of dementia individuals being clinically identified. AD is the major neurodegenerative disorder leading to dementia, characterized by neuronal atrophy and loss. The accumulation of toxic amyloid-beta (Aβ) oligomers, protein aggregates, along with the formation of neurofibrillary tangles (NFTs) within neurons, is the key pathological feature of AD. NFTs are composed of hyperphosphorylated tau protein. These abnormalities contribute to a decline in cerebral glucose metabolism in the brain, synaptic dysfunction, and mitochondrial impairment. The progression of AD occurs in three stages: (1) the presymptomatic stage, (2) mild cognitive impairment (MCI), and (3) the clinical stage of AD. Many biomarkers have been identified for diagnosing AD and differentiating it from atypical AD. It has emerged as a key area of research, offering significant potential for early detection of AD, prognostication, as well as planning drug therapy and monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansBiomarkersDisease ProgressionCognitive DysfunctionAmyloid beta-PeptidesNeurofibrillary Tanglestau Proteins

Substanzen

BiomarkersAmyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Principal-Director Senior Consultant, Department of Neurology, BLK-Max Super Speciality Hospital; MAX Healthcare, Delhi, India, Corresponding Author.
  • Professor, Department of Neurology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.
  • Associate Consultant, Department of Neurology, BLK-Max Super Speciality Hospital; MAX Healthcare, Delhi, India.

Zitieren

APA

Mehndiratta, M. M., Singla, M., & Dixit, A. (2025). Unlocking the Future of Alzheimer's Disease: Innovations in Diagnosis and Therapy. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.73.1075

Vancouver

Mehndiratta MM, Singla M, Dixit A. Unlocking the Future of Alzheimer's Disease: Innovations in Diagnosis and Therapy. Journal of The Association of Physicians of India. 2025. doi:10.59556/japi.73.1075

BibTeX
@article{Mehndiratta2025,
  author = {Mehndiratta, Man Mohan and Singla, Monika and Dixit, Abhishek},
  title = {Unlocking the Future of Alzheimer's Disease: Innovations in Diagnosis and Therapy},
  journal = {Journal of The Association of Physicians of India},
  year = {2025},
  doi = {10.59556/japi.73.1075}
}
Kostenlos starten →